Biomimetic total synthesis of sarglamides A, B, C, unnatural-natural sarglamide G and their enantiomers

16 April 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Herein, we report the first biomimetic asymmetric total synthesis of sarglamides A, B and C, recently isolated from a shrub of the genus Sarcandra. Our synthesis features an efficient one-step intermolecular [4+2] Diels-Alder cycloaddition between (S)-⍺-phellandrene and both enantiomers of toussaintine C, which proceeds with an endo-selectivity to give these 6/6/6/5 tetracyclic structures comprising seven stereogenic centers. By this approach, we also elaborated a sarglamide that had not been isolated, which we named sarglamide G. It resulted from the Diels-Alder reaction of (S)-⍺-phellandrene with (R,R)-toussaintine C via an endo ortho transition state. Importantly, our study provides the shortest route to this family of unique indolidinoid-monoterpenoid hybrids, as well as strong evidence to support their putative biosynthesis.

Keywords

Diels-Alder
Biomimetic synthesis
Sarglamides

Supplementary materials

Title
Description
Actions
Title
Supporting information
Description
1-1 General Information 1-2 Experimental procedures 1-2-1 Preparation of (±)-toussaintine C (1) 1-2-2 Preparation of (S)-α-phellandrene (2) 1-2-3 Optimization of the cycloaddition conditions under microwave heating 1-2-4 Synthesis of sarglamides A (3), B (4), G (5), C (6) and compounds 12-14 1-2-5 Synthesis of ent-sarglamides A (17), G (18), C (19) and compounds 20-22 2- Structural elucidation: 1H and 13C NMR data of compounds 3-6, 11-13, 17-22 3- X-ray crystallographic analysis 4- 1H and 13C spectra of all compounds, COSY, HMBC, HSQC and NOESY spectra of compounds 5, 11, 12, 13, 21 28
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.